Remote Jobs at Lycia Therapeutics
Lycia Therapeutics
Lycia is a Series B biotech company building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University to develop LYTAC (lysosomal targeting chimera) protein degraders that harness the cell’s lysosomal trafficking and degradation pathway to target both soluble and membrane-bound extracellular proteins. Applications of the LYTAC platform include: targeting challenging membrane proteins, clearing pathogenic immune complexes in circulation and depleting antibodies to specific antigens of interest. The platform can potentially deliver next-generation therapeutics to address a range of difficult-to-treat diseases, including cancer and autoimmune diseases.
11 - 50 employees
💰 $70M Series B on 2021-09
July 19
Lycia Therapeutics
11 - 50
Lead global regulatory strategy for innovative therapeutics degrading extracellular and membrane-bound proteins.
🇺🇸 United States – Remote
🏄 California – Remote
💰 $70M Series B on 2021-09
⏰ Full Time
🔴 Lead
🚔 Compliance
